
12 August 2025
Xaar plc
2025 INTERIM RESULTS
KEY PROSPECTS PROGRESSING IN LINE WITH EXPECTATIONS
Xaar plc ("Xaar", the "Group" or the "Company"), the leading inkjet printing technology group, today announces its unaudited interim results for the six months ended 30 June 2025.
Financial Summary:
Continuing operations: | H1 2025 | H1 20241 | Change |
Revenue | £27.2m | £25.5m | 7% |
Gross margin % | 36.5% | 37.4% | (90)bps |
Gross R&D investment2 | £2.0m | £2.0m | (1)% |
Adjusted EBITDA3 | £0.76m | £0.90m | (15)% |
Adjusted profit / (loss) before tax | (£0.70m) | (£0.64m) | (9)% |
Reported loss for the period | (£2.6m) | (£1.8m) | (49)% |
Adjusted earnings per share | (0.7p) | (0.6p) | (25)% |
Basic earnings per share | (3.3p) | (2.3p) | (48)% |
| | | |
Total operations: | | | |
Reported loss for the period | (£3.1m) | (£2.6m) | (19)% |
Basic earnings per share | (3.9p) | (3.3p) | (18)% |
Net cash/(debt) at period end4 | £5.1m | £8.2m5 | (38)% |
Financial Highlights:
- H1 2025 performance as expected with revenue up 7% to £27.2 million (H1 2024: £25.5 million)
- Printhead revenue up 20% to £19.9 million (H1 2024: £16.5 million), contributing 73% of Group total, led by jewellery wax revenue growing from £0.6 million in H1 2024 to £3.3 million in H1
- Printhead operating margin up 70 bps to 10.4% driven by robust pricing decisions and tight cost control
- Printhead new business6 revenue growth of 96% to £9.8 million (H1 2024: 5.0 million)
- Ceramics and Glass beginning to stabilise with revenue of £3.6 million (H1 2024: £3.8 million)
- Engineered Print Systems' (EPS) revenue declined 16% to £6.3 million (H1 2024: £7.5 million) driven by hesitant capital investment from tariff uncertainty; pipeline now rebuilding
- Proactive cost management across the Group with gross margin stable at 36.5% (H1 2024: 37.4%). Adjusted operating expenses well controlled at £10.5 million (H1 2024: £10.0 million)
- R&D investment at c.7% of revenue to capture new market opportunities
- Reduction in net cash due to investment in capital equipment and development spend to drive future growth
Strategic Highlights:
- Jewellery wax: Our partner OEM, Flashforge, launched their Waxjet 530 printer in April 2025 with strong revenue growth. New to this market, we have taken considerable share ahead of plan through all our OEM partners
- Electric vehicle battery coating: Collaboration with Sokan announced, alongside partnerships with Shifang and Omijia, for the production of next-generation battery coating solutions
- Automotive coating: Axalta and Dürr demonstrating technology to premium car manufacturers and now receiving first quote requests for mid 2026 deliveries
- Desktop 3D printing: Learning from peer success with a similarly priced 2.5D product, Flashforge will launch with a more direct go-to-market strategy around year end
John Mills, Chief Executive Officer, commented:
"The start of 2025 has been encouraging with the swift progress made in the jewellery wax market, reflecting the disruptive impact our technology will have in our target markets once OEM products have been launched.
Opportunities in EV battery coating, automotive coating and desktop 3D are setting the Group up for sustainable medium-term growth with key developments within each market progressing as planned. As expected, EPS performance is constrained due to tariffs adding to existing end market uncertainty and historic weakness in the order pipeline. However, this is being addressed, and we look forward with increased optimism in the medium-term prospects of this business.
Alongside a strong balance sheet, the Group remains well positioned to deliver on the substantial opportunities in front of us, and we look forward to generating accelerating growth to the benefit of our shareholders."
Outlook
Our expectations for 2025 remain unchanged despite the additional uncertainty brought by the introduction of tariffs and the continuation of challenging trading conditions reported in March 2025. Our strength is our attractive value proposition centred around the ability to jet highly viscous liquids.
We continue to anticipate that revenue will be second half weighted with order volumes expected to grow steadily throughout the year and into FY26. Printhead revenue is expected to be strong in the second half, whilst in EPS, the tariff induced end market slowdown is expected to continue to impact revenue and profit whilst the pipeline is being rebuilt.
Notwithstanding the uncertainties of the global geopolitical environment and tariffs, our financial performance will be driven by the maturing of recent product launches and the exact timing of new ones. Management remains confident of meeting current expectations.
It also remains our strong belief that in the medium term, our focus growth areas will deliver meaningful revenue at attractive margins.
Contacts
Xaar plc | +44 (0) 1223 423 663 |
John Mills, Chief Executive Officer | |
Paul James, Chief Financial Officer | |
Investor Relations | |
Stephen Lamacraft | |
Daniel Verity
| |
A presentation for analysts and institutional investors will be held via webcast at 09:00 today. To access the meeting, please sign up using the following link: Xaar Interim Results 2025. For further details, please contact Xaar_IR@cen-grp.com.
1 Prior year numbers restated to reflect continuing operations post the disposal of FFEI Life Science business.
2 Group R&D investment exclusive of any capitalised costs as used to determine adjusted profit before tax.
3 EBITDA is calculated as statutory operating profit before depreciation, amortisation and impairment of property, plant and equipment, intangible assets, and goodwill. Adjusted EBITDA is calculated as EBITDA excluding other adjusting items as defined as follows. Adjusted Measures exclude the impact of share-based payment charges, exchange differences relating to intra-group transactions, gain on derivative financial instruments, restructuring and transaction expenses, research and development expenditure credit, fair value loss or gains on financial assets at FVPL, amortisation of acquired intangibles, and discontinued operations as reconciled in note 3.
4 Net cash includes cash, cash equivalents and treasury deposits, net of invoice discounting facility.
5 Net cash/(debt) as of 31 December 2024
6 New business is defined as revenue from the sale of printheads used in OEM products that have been launched since 2019.
Figures and percentages included in this report are subject to rounding adjustments arising from conversion to £millions from actual figures. Accordingly, figures shown for the same category presented in different tables may vary slightly, and figures shown as totals in certain tables may not be an arithmetic aggregation of the figures that precede them.
About Xaar plc
Xaar is an inkjet innovator, providing printheads and technologies for Original Equipment Manufacturer (OEM) and User Development Integrator (UDI) customers worldwide.
We develop and manufacture reliable and technically advanced printheads that enable end customers to produce high quality results for both existing and new applications. Our precision inkjet technology facilitates the use of high viscosity inks, which are thicker with less permeation into surfaces, meaning improved print consistency and uniformity. These unique characteristics also typically have lower financial, environmental, water and energy costs, creating less fluid waste than other fluid application methods. We are the only printhead manufacturer that can reliably jet inks up to and above 100 centipoise[1] at jetting temperature (1000 cP at ambient temperature), with our nearest competitor limited to printing inks with less than a third of this viscosity.
By helping customers lay down precise volumes of high viscosity inks and fluids with absolute pin- point accuracy, time after time, Xaar's inkjet printheads and technologies meet the needs of numerous markets. Not only do we provide solutions for traditional 2D printing, but our technology also facilitates the laying down of complex fluids onto surfaces to create 3D images.
Collaboration is at the very core of our business. Xaar works as a trusted partner from sites in Europe, North America and China, providing expert insights and technical support every step of the way. With over thirty years' experience, around 150 patents registered or pending, and major ongoing R&D investment, Xaar's digital printhead and precision jetting technologies create countless opportunities for today's growing sustainable manufacturing requirements.
Chief Executive Officer's Statement
Market recognition of our technology's ability to act as an enabler for new applications continues to gain momentum. Focussing on sizable new applications, such as EV battery coating, automotive coating and desktop 3D printing, where the incumbent solution is either technologically limited, too expensive or too inefficient, represents the main medium-term revenue opportunity, with each avenue for growth showing strategic progress.
In the near-term, the jewellery wax market, another of our key focus areas, highlights the disruptive and rapid scaling potential of our technology. From a standing start in 2023, we now supply printheads to four of the five largest players and we expect to have secured substantial share by the year end. With the opportunities within our other key markets progressing well, the wax success illustrates the expected commercial ramp up once we have leading participants adopting our technology.
The weak performance of EPS has resulted in a Group performance headwind partially offsetting the revenue growth from new Printhead business which is defined as revenue generated from the sale of printheads used in OEM products that have been launched since 2019. However, with 96% printhead new business revenue growth year-on-year, and a CAGR of 26% since 2019, new printhead products now account for 49% of divisional revenue. The increased diversification of the business, compared to historic overreliance on the ceramics market, ensures that the foundations for the future are well set.
Financial Highlights
During the first half of 2025, we delivered 7% revenue growth to £27.2 million (H1 2024: £25.5 million) against a period of heightened global market uncertainty given the dynamics in the US. Printhead revenue grew £3.4 million, 20% year-on-year, bolstered by significant revenue growth within the jewellery wax market with £3.3 million of revenue up from £0.6 million in H1 2024. Printhead revenues also benefited from decreasing instability in the ceramics market; the Ceramics and Glass segment generated £3.6 million of revenue in H1 2025 (H1 2024: £3.8 million). Continued momentum in our new printhead business alongside the reduced headwind from ceramics bodes well for the future of the business.
Revenue for EPS fell £1.2 million to £6.3 million (H1 2024: £7.5 million), with the previous period benefitting from a multi-year, multi-unit order from a single customer and market uncertainty continuing to delay the rate of new customers switching from analogue to digital. However, under new management, the order book is being rebuilt which should translate to revenue growth in 2026.
Megnajet has also been impacted by a weaker capital investment environment caused by higher uncertainty as revenue decreased £0.2 million to £1.1 million (H1 2024 £1.3 million).
We continue to make operational efficiency savings, with gross margin remaining stable at 37% and operating expenses remaining broadly flat.
The Group continues to retain a strong balance sheet, with a net cash position at period end of £5.1 million, down 38% from £8.2 million at the end of 2024, partly as a result of ongoing investment in capital equipment and capitalised R&D spend. This expenditure is driven by our commitment to develop cutting edge, unique technology which will open up new opportunities for Xaar in the future. While we remain focussed on delivering the opportunities in front of us, and will utilise cash accordingly, we will continue to invest for the long-term benefit of the Group.
Strategic Update
The almost universal acceptance and adoption of our technology in the jewellery wax market is a significant milestone for Xaar, providing the strongest evidence yet that our technology can be transformative in end markets, once adopted. When the first major OEM launched a product using our printheads, competitors were compelled to rapidly launch similar products to match the performance that our printheads deliver. As a result, we have progressed from zero to significant market share within two years.
Elsewhere, progress within the major opportunities of EV battery coating, automotive coating and desktop 3D printing markets remains encouraging and in line with our expectations. These markets each have substantial long term and repeat revenue potential and are central to the strategic growth ambitions of the Company. As we become increasingly embedded with our customers, with our technology playing a key role in their market share aspirations, the durability of our revenue is enhanced.
With additional opportunities in markets such as textiles and corrugate, as well as the potential for a cyclical recovery in ceramics, our product portfolio has much more diversity in end markets and customers than it has ever had, providing both revenue growth optionality and a more resilient and stable foundation going forward. By focussing on applications where our printheads are opening up new markets or revolutionising the existing market, rather than competing on price and quality alone, we can take significant share across several substantial markets in the medium-term.
Printhead
EV Battery Coating opportunity
The problem we solve: New 800-volt battery technology, which incorporates faster charging times, increases heat generation which can be incompatible with current battery coating techniques. This is the primary issue with the incumbent solution, which utilises a plastic wrap to insulate batteries. Using spray painting to insulate the battery overcomes this drawback. However, with c.40% of paint being lost in the process, this requires a paint recovery system which generates incremental costs, severely limiting its uptake with EV battery manufacturers. As demand for higher voltage EV batteries increases, so does the demand for a high-yield, low-cost solution that eliminates the risk of air bubbles caused through delamination of plastic film technology, has greater rub resistance and peel strength whilst also being fire retardant with higher thermal properties.
Storage batteries provide a further incremental opportunity for Xaar as these also have a coating requirement and customers in this market face the same issues as EV manufacturers.
The Xaar solution: Inkjet coated EV batteries, as enabled by Xaar technology, can withstand far greater levels of heat than plastic wrapping and have a significantly higher yield than spray painting, meaning minimal waste with no need for a costly paint recovery system. As well as addressing safety concerns, research has shown that switching from the incumbent film technology to inkjet substantially reduces cost per unit.
The maturity of the opportunity: A year ago we launched two new printheads, the Xaar eX and Nitrox eX, specifically designed to print a coating solution that meets the necessary safety tests for the insulation of the new generation of batteries used in EVs and energy storage systems.
We have worked with Shifang, a leader in EV battery production automation, Omijia Intelligent Technology, and Sokan New Materials Group, to launch their own inkjet battery coating lines. These OEMs provide lines to the leading battery manufacturers meaning that our technology is on the cusp of becoming a critical part of an expanding industry.
Our product offering has been in the market for nine months now and this year will generate single-digit million revenue from existing orders, with all three OEM's signalling their intent to ramp up order volumes in the near future. As such, we are well positioned to signficantly grow printhead sales as confidence in inkjet coating technology increases.
The market potential: We are the leading provider of this technology with others unable to handle the viscosity of fluids that are required for this application. There are an estimated 1,300 EV battery production lines in China and we expect this number to increase as demand for EV's and battery storage continues to grow. To scale this opportunity for Xaar, converting just the existing market could generate over a hundred million pounds of initial revenue over a number of years and with an estimated printhead replacement cycle of two to three years, we anticipate healthy repeat revenue once our technology has been installed.
Automotive Coating opportunity
The problem we solve: Today the only solution to using graphics on a car is either through extremely expensive hand painting or the use of decals. Decals can quickly appear dirty around the edges and are prone to jet wash damage which has historically limited their appeal.
In addition, as a potentially secondary opportunity in the more medium term, if manufacturers want to use several colours on their vehicles, even something as apparently simple as a different colour roof, it is an extremely inefficient process. Here, the current process requires cars to be taken off the production line then masked and sprayed prior to the application of every additional colour. This is inefficient in terms of both materials and energy with c.40% of paint lost when spray painting.
The Xaar solution: With a focus on graphic applications, and the replacement and expansion of the existing "decal" market, Xaar technology enables high viscosity ink to be applied on the production line on any angle of surface, providing a high-quality, high value solution with no risk of damage. As such, last year Axalta and Dürr announced a partnership to provide a digital graphic solution utilising Xaar printheads and combining Axalta's coating technology with Dürr's robotics.
The maturity of the opportunity: Dürr, whose machines currently paint 50% of cars globally, have demonstrated this technology to potential customers and are in the process of choosing go-to-market partners. During the second quarter of 2025, they received their first inbound request to quote from a luxury car manufacturer, an important milestone indicating demand for our technology. We currently estimate that the first installations will be in the second half of 2026. The exact timing of when this opportunity will start to deliver sizeable revenue remains uncertain due to the unpredictability of when the car industry decides to adapt this new technology.
The market potential: Our technology could drastically expand capability for customers or brands to customise vehicles beyond what is available today. As such, exact demand levels are difficult to predict, however, it is likely to be considerably greater than existing demand for traditional decal solutions given its limitations.
Currently only c.1% of the 90 million cars produced globally have decals or two-tone paint. As the current sole provider of this new technology, we have the potential to take 100% of the market. Unlike our traditional model of generating revenue directly from selling printheads, Xaar will receive revenue based on the number of cars painted. We anticipate the size of this market will grow as our technology unlocks new uses for decals. Therefore, every 1% of the global car market, or 900,000 cars annually that are painted using our technology, would generate significant revenue at attractive margins for Xaar.
Desktop 3D Printing opportunity
The problem we solve: Historically there has been an absence of a low-cost, high-quality, full colour-enabled product. Consumers had a choice between cheap single nozzle, monochrome, 3D printers or high-quality, full colour 3D printers which can cost in excess of £50,000. Accessibility to high quality 3D printers was therefore restricted to real enthusiasts willing to pay for a premium product.
The Xaar solution: By utilising Xaar technology and jetting high viscosity fluids, cost as a barrier to high-quality 3D printing, has been substantially reduced. In November 2024, our technology enabled Flashforge, a major global supplier of desktop 3D systems, to launch the world's first full colour high resolution desktop 3D printer with keen pricing aimed at opening up the consumer market.
Of note, earlier this year, an OEM launched a 2.5D full colour printer at a similar price point to the Flashforge system. The overwhelmingly positive reaction to this launch, with sales a multiple of that initially expected, has served to reinforce belief in the market potential for a high quality full colour 3D printer. Flashforge have observed how their competitor launched their product and are currently implementing key lessons with a modified go-to-market strategy.
The maturity of the opportunity: Flashforge have been marketing their desktop 3D printer for an extended period and we anticipate that they will start to sell their printers around year-end, with a more direct go-to-market strategy than initially envisaged given peer success.
The market potential: As the cost of purchasing a high-quality desktop 3D printer falls over the medium term, we would expect demand to grow beyond the current levels of one million units sold annually. Conversion of just 1% of the existing market will generate Xaar multi-million-pounds of revenue with each machine generating reoccurring revenue as the printheads are designed for regular replacement.
Summary of the key future revenue drivers
Overall, these three markets each represent significant revenue opportunities, illustrating the progress we have made to de-risk our business over a relatively short period of time. In the first half of 2025, progress in all three markets has remained on schedule and demand for our printheads continues to grow.
Other Market opportunities
Jewellery wax market: We now supply printheads to four of the five biggest OEMs in the market and we expect to take a majority share of the market by year-end. Most recently, in April 2025, Flashforge launched the Waxjet 530, a three-headed machine to go alongside the Waxjet 510, a single headed machine, which launched last year, and demand for the Waxjet 530 has been almost double than anticipated. On top of this, we have started the multi-year process to develop a printhead that will enable access to an adjacent market which has more than double the revenue potential than the current opportunity.
Textiles and Corrugates: Our technology enables consistently clean, high-quality printing on a wide range of garments. Following a successful launch with M&R utilising our Aquinox printhead in a textile application, we remain committed to the opportunity to broaden our offering to additional OEMs. The potential market opportunity is roughly £20 million per annum and we anticipate taking significant market share in the medium term.
Enhanced go-to-market strategy
The capability of OEMs to integrate our printheads into their existing print machines varies materially. The challenges of working with high viscosity fluids can be considerable, with clients, on occasion, withdrawing from the development process due to the apparent complexity of the process. To get around this, in some markets we have been changing our go-to-market strategy to focus on turnkey solutions that offer potential customers the printhead with the associated ink system. The critical advantage of a turnkey solution is a significantly reduced timeline from point of engagement to a Xaar embedded solution being fully operational and available for customers to purchase.
After the success of the project in collaboration with M&R last year, which saw their product launched in early September after just six months, our go-to-market strategy has been validated. However, the near-term focus remains on executing on the opportunities within EV battery, automotive coating and desktop 3D, as well as the jewellery wax market in the immediate future.
Operations
The capability to increase operational capacity and output in line with anticipated increases in demand, without the need for significant capital investment, ensures we are well set for the growth we see before us. On a smaller scale, our ability to ramp-up in line with demand was proven as we met the stronger than anticipated demand for Xaar 2002 printheads post the successful launch of the Flashforge 530 Waxjet in April 2025; delivering in H1 the number of printheads forecast for FY25 in total on schedule. Further to this, we have begun to add headcount in key areas in anticipation of growing demand for our printheads.
Last year we successfully relocated print systems manufacturing from Hemel Hempstead to Huntingdon as part of our continued effort to facilitate greater collaboration. This enables us to understand integration issues and provide functioning solutions to our OEMs faster, making it easier for OEMs to utilise our technology, ultimately allowing us to sell more printheads.
Megnajet
Megnajet continues to play an important role in helping OEMs utilise our printheads and we are in the process of further integrating Megnajet with our Printhead business.
We have built a new ink delivery system production facility in China to expand our ability to support local OEMs with the products they need. Historically, we have been unable to sell any ink systems in China as the cost of UK manufactured ink systems was too high for the domestic market. This facility helps us to support our customers with the hardware they need at the right price, therefore removing another hurdle to the adoption of our printheads in China.
Engineered Print Systems
EPS remains largely separate to the rest of our business with a distinct strategy and business model, utilising both Xaar and competitor printheads. Amidst a difficult market backdrop, worsened by the introduction of tariffs, we have taken steps to strengthen the leadership of this business to focus on a return to growth. Going forward, our focus will be on strengthening the customer pipeline while optimising the supply chain to reduce the effects of higher input costs. The benefits of these actions should be delivered in the next financial year.
Sustainability
We remain focussed on delivering our roadmap and helping our customers become more sustainable by using our printheads which need less ink, require less time to dry and consume less energy. Our research shows that, compared to analogue alternatives, digital has a significant impact in reducing energy consumption (by as much as 55%), water consumption (by up to 60%) and CO2 emissions (by up to 95%).
After the relaunch of our roadmap in April 2025, we are currently focussing on developing the necessary action plans that will ensure we meet our targets as planned. Our 2024 ESG report provides further detail of our programme, including progress against each of our pillars.
Outlook
Our expectations for 2025 remain unchanged despite the additional uncertainty brought by the introduction of tariffs and the continuation of challenging trading conditions reported in March 2025. Our strength is our attractive value proposition centred around the ability to jet highly viscous liquids.
We continue to anticipate that revenue will be second half weighted with order volumes expected to grow steadily throughout the year and into FY26. Printhead revenue is expected to be strong in the second half, whilst in EPS, the tariff induced end market slowdown is expected to continue to impact revenue and profit whilst the pipeline is being rebuilt.
Notwithstanding the uncertainties of the global geopolitical environment and tariffs, our financial performance will be driven by the maturing of recent product launches and the exact timing of new ones. Management remains confident of meeting current expectations.
It also remains our strong belief that in the medium term, our focus growth areas will deliver meaningful revenue at attractive margins.
Business Performance
Revenue
Group revenue growth
£m | H1 2025 | H1 20241 | Var | Var % |
Printhead | 19.9 | 16.5 | 3.4 | 20% |
EPS | 6.3 | 7.5 | (1.2) | (16)% |
Megnajet | 1.1 | 1.3 | (0.2) | (19)% |
FFEI | - | 0.2 | (0.2) | n/a |
Total Revenue | 27.2 | 25.5 | 1.7 | 7% |
1Prior year numbers restated to reflect continuing operations post the disposal of FFEI Life Science business
Revenue for the Group was £27.2 million (H1 2024: £25.5 million) for the first half of the year, representing year-on-year growth of £1.7 million, up 7%. Growth is reflective of strong Printhead new business revenue growth as well as relative stability in our Ceramics and Glass product offering, which has been in decline and acting as a headwind to Group growth for a number of years. In total, revenue from the Printhead business grew by £3.4 million, largely due to demand for our jewellery wax printheads which generated £3.3 million of revenue in H1, up from £0.6 million in the first half of 2024.
FFEI revenue in H1 2024 is for the Digital Print part of that business which is continued within the Printhead business unit in 2025.
EPS revenue fell 16% to £6.3 million amidst tough market conditions driven by tariff uncertainty in the US market affecting capital investment decisions in the customer base and the completion of a substantial multi-year project in FY24.
Megnajet revenue was down year-on-year to £1.1 million (H1 2024: £1.3 million) as the uncertainty caused by tariffs has slowed down capital investment decisions.
Printhead
Revenue by Sector
£m | H1 2025 | H1 20241 | Var | Var % |
Ceramics & Glass | 3.6 | 3.8 | (0.2) | (9)% |
C&M & DTS | 7.1 | 6.4 | 0.7 | 11% |
WFG & Labels | 1.2 | 2.4 | (1.2) | (50)% |
3D Printing & AVM | 6.7 | 3.5 | 3.2 | 91% |
Packaging & Textiles | 1.3 | 0.5 | 0.8 | 160% |
Total Revenue | 19.9 | 16.5 | 3.4 | 20% |
1Note that 2024 sector revenues have been restated following a review of allocations for FY24 results
Xaar offers a wide range of industrial inkjet printheads which are designed and produced to meet customer-driven requirements in markets including EV battery coating, automotive coating, 3D printing, jewellery wax, textiles, graphics, packaging, and additive manufacturing.
Printhead revenue increased by 20%, to £19.9 million for H1 2025 (H1 2024: £16.5 million). The Coding & Marking (C&M) and Direct-to-Shape sector revenue grew £0.7 million to £7.1 million, primarily due to revenue generated from the EV battery coating market. 3D Printing and Advanced Manufacturing grew 91% due to the significant growth in the jewellery wax market. Packaging and Textiles, was up 160% to £1.3 million in H1, largely due to the M&R partnership launched in September 2024. The decline in revenue from Ceramics and Glass has begun to stabilise to £3.6 million compared to £3.8 million in H1 2024, supported by a new agreement with a key customer. We anticipate that revenue from this sector is near its trough, eliminating a persistent headwind for the Group. Revenue excluding Ceramics and Glass increased by 28%, to £16.3 million (H1 2024: £12.7 million).
Overall, as we grow revenue, we are also growing market share through entry into new markets. This supports our confidence that as more of our technology becomes embedded in our target end markets, the Printhead business will deliver strong and sustainable growth.
Engineered Print Systems
EPS manufactures a range of highly customised product print systems, printing a variety of industrial and promotional objects such as tools, appliances, sports equipment, medical equipment and toys. The business is split between digital inkjet machine sales (H1 2025: 52% of revenue), pad printing sales (H1 2025: 40% of revenue) and servicing (H1 2025: 8% of revenue).
Revenue from EPS fell by £1.2 million to £6.3 million (H1 2024: £7.5 million). This has been driven by a £1.4m fall in sales of digital inkjet to £3.2 million (H1 2024: £4.6 million), driven in part by the global uncertainty that US tariffs brought - causing customers to delay capital investment decisions. Pad printing remains flat at £2.5 million. Servicing continues to be a positive contributor to growth as customers look to extend the lifespan of machinery, with revenue up 47% to £0.5 million.
Megnajet
Megnajet specialises in the design and manufacture of industrial fluid management systems for digital inkjet with the most integrated and compact ink systems in the market today.
Megnajet delivered £1.1 million of external revenue, a 19% reduction year-on-year due to the ongoing delay of capital equipment investment caused by higher uncertainty. Within Megnajet, our main focus is on Group projects, with a 133% uplift in intra-group transactions with Xaar and EPS remaining two of Megnajet's biggest customers. Overall, we remain satisfied with the performance of this business as it contributes to the strategic progress of the Group.
Gross profit
Gross profit increased by £0.4 million to £9.9 million (H1 2024: £9.5 million) with gross margin remaining stable at 36.5% (H1 2024: 37.4%) on increased revenue.
Printhead gross margin decreased by 350 basis points year-on-year driven by sales mix and a strategic decision to secure market share in the ceramics segment in anticipation of its recovery. Within EPS, gross margin improved by 350 basis points due to cost savings achieved by the new management team including proactive supply chain management. Megnajet gross margin fell by 480 basis points due to a reduction in externally sold volumes and lower overhead absorption.
Research & Development
Gross R&D was £2.0m in the first half, and at c7% of revenue was in line with the prior year. We are continuing to invest in the business for both the short and long-term benefit. We remain focussed on helping OEM companies integrate our technology into their machines whilst remaining at the forefront of innovation.
Operating Expenses
Whilst we have continued to face inflationary headwinds in areas such as raw material and energy costs, we have been successful in our efforts to manage operating expenditure across the Group. The sales and marketing expense for the period was £2.3 million (H1 2024: £2.5 million) reflecting the continued focus on cost management across both salaries and travel expense. General and administrative expenses increased to £6.2 million from £5.5 million (restated) in H1 2024, reflecting small headcount growth, inflationary salary increases and extra IP and legal costs.
Profit for the year
Adjusted loss before tax was at a similar level to the prior period at £(0.7) million (H1 2024: £(0.6) million). All business units continue to generate profit although in the period this was offset by broadly stable head office costs at £3.1 million (H1 2024 £3.0 million).
In calculating the adjusted profit before tax, we have adjusted for fair value losses on financial assets of £0.4 million (H1 2024: £0.2 million) alongside restructuring costs of £0.7 million (H1 2024: £0.2 million), foreign exchange losses on intra-group loans of £0.6 million (H1 2024: nil), share-based payments of £0.4 million (H1 2024: £0.7 million), Research and development expenditure credit £0.2 million (H1 2024: nil), and amortisation of acquired intangible assets of £0.2 million (H1 2024: £0.3 million). After taking these into account, the loss before tax was £2.8 million (H1 2024: £2.0 million)
Adjusted EBITDA in the period was £0.8 million (H1 2024: £0.9 million).
Cashflow and balance sheet
The Group retains a strong balance sheet, with cash and cash equivalents at 30 June 2025 of £5.1 million, reflecting a cash outflow of £3.6 million during the period.
H1 2025 saw trade working capital fall £1.1 million to £25.4 million (FY 2024: £26.5 million). Trade receivables were flat at £8.1 million and trade creditors reduced by £0.3 million to £8.5 million (FY 2024: £8.8 million). Whilst inventory reduced by £1.4 million in the statement of financial position to £25.9 million (FY 2024: £27.2 million), £0.9 million of this has no cashflow impact as it was transferred to fixed assets to enhance demonstration capability.
Trading losses before tax from total operations of £3.3 million resulted in operating cash outflows of £0.3 million after adjusting for non-cash items. The cash impact of movements in working capital was an outflow of £0.6 million, predominantly driven by changes to creditor balances including lower contract liabilities in EPS, and drives a cash utilisation from operations of £0.9 million.
Other significant financing and investing cashflows include purchases of fixed assets £1.3 million, purchases of own shares £0.3 million, lease payments £0.8 million and a repayment of receivables finance borrowings £0.5 million.
As at 30 June 2025 there were no borrowings against receivables (FY 2024: £0.5 million borrowed) and this movement, alongside the £3.6 million gross cash reduction, resulted in a reduction in net cash from £8.2 million to £5.1 million.
The Group has a Revolving Credit Facility (RCF) of £5 million in place with our lead bank, HSBC, to ensure we have adequate resources to invest in the Group and our operational capability when required. To date the facility remains undrawn. At the beginning of the year, the term of the facility was extended by one year, to June 2026.
The business has a clear plan and strategy, supported by its healthy balance sheet and cash position. At present, we are focusing on internal investment to ensure we have the operational capacity and efficiency to meet future demand, as well as product development to ensure we remain at the forefront of the high viscosity printhead market. We remain focussed on converting market opportunities and will continue to review our approach to inventory levels, with a medium-term aim to reduce it as demand becomes more stable.
Dividend
The Board regularly reviews capital allocation and believes that prioritising investment to enable profitable growth for the business is currently the most appropriate use of capital, therefore, no interim dividend has been declared for H1 2025.
CONDENSED CONSOLIDATED INCOME STATEMENT
FOR THE SIX MONTHS ENDED 30 JUNE 2025
|
| Six months ended 30 June 2025 (unaudited) | Six months ended 30 June 2024 (unaudited) - restated ** | ||||
| | Adjusted | Adjusting Items* | Total | Adjusted | Adjusting Items* | Total |
Notes | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Revenue | 2 | 27,211 | - | 27,211 | 25,533 | - | 25,533 |
Cost of sales | | (17,270) | - | (17,270) | (15,985) | - | (15,985) |
Gross profit | | 9,941 | - | 9,941 | 9,548
| - | 9,548
|
Selling, general and administrative expenses |
3 | (8,481) | (2,263) | (10,744) | (8,014) | (1,321) | (9,335) |
Research and development expenses | | (1,974) | 181 | (1,793) | (2,001) | - | (2,001) |
Operating loss | | (514) | (2,082) | (2,596) | (467) | (1,321) | (1,788) |
Finance income | | 39 | - | 39 | 42 | - | 42 |
Finance costs | | (227) | - | (227) | (217) | - | (217) |
Loss before tax | | (702) | (2,082) | (2,784) | (642) | (1,321) | (1,963) |
Tax credit | 4 | 135 | 16 | 151 | 191 | - | 191 |
Loss for the period from continuing operations | | (567) | (2,066) | (2,633) | (451) | (1,321) | (1,772) |
Loss for the period from discontinued operations | | (178) | (300) | (478) | (48) | (797) | (845) |
Total loss for the period | | (745) | (2,366) | (3,111) | (499) | (2,118) | (2,617) |
Loss per share | |
|
|
| | |
|
Basic | 5 | (0.9) |
| (3.9) | (0.6) | | (3.3) |
Diluted | 5 | (0.9) |
| (3.9) | (0.6) |
| (3.3) |
Loss per share - continuing operations | |
|
|
| | |
|
Basic | 5 | (0.7) |
| (3.3) | (0.6) | | (2.3) |
Diluted | 5 | (0.7) |
| (3.3) | (0.6) |
| (2.3) |
*Further information on adjusting items included in Note 3.
** Prior period figures have been restated to separately disclose discontinued operations. Refer note 12.
STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHS ENDED 30 JUNE 2025
| Six months ended 30 June 2025 (unaudited)
£'000 | Six months ended 30 June 2024 (unaudited) - restated* £'000 |
Loss for the financial period | (3,111) | (2,617) |
Exchange (losses)/gains on translation of foreign operations | (488) | 47 |
Other comprehensive (expense)/income for the period | (488) | 47 |
Total comprehensive expense for the period | (3,599) | (2,570) |
|
| |
Total comprehensive income for the period is attributable to: |
| |
Continuing operations | (3,121) | (1,725) |
Discontinued operations | (478) | (845) |
| (3,599) | (2,570) |
* Prior period figures have been restated to separately disclose discontinued operations. Refer note 12.
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION | | ||
AS AT 30 JUNE 2025 | |||
| | As at | As at |
| | 30 June 2025 | 31 December 2025 |
| Notes | (unaudited) | (audited) |
Non-current assets | | | |
Goodwill | | 6,477 | 6,959 |
Other intangible assets | | 5,434 | 5,136 |
Property, plant and equipment | | 12,838 | 12,490 |
Right-of-use assets | | 4,363 | 4,734 |
Financial asset at fair value through profit or loss | 6 | 2,718 | 3,063 |
Deferred tax assets | | 1,068 | 951 |
Non-current financial assets | | 95 | 104 |
| | 32,993 | 33,437 |
Current assets | | | |
Inventories | | 25,863 | 27,236 |
Trade and other receivables | | 8,069 | 8,084 |
Contract assets | | 772 | 1,018 |
Current tax receivable | | 504 | 346 |
Financial asset at fair value through profit or loss | 6 | 1,695 | 1,854 |
Cash and cash equivalents | | 5,092 | 8,711 |
| | 41,995 | 47,249 |
Total assets | | 74,788 | 80,686 |
Current liabilities | | | |
Trade and other payables | | (8,495) | (8,782) |
Provisions | | (902) | (951) |
Contract liabilities | | (1,320) | (1,986) |
Borrowings | 7 | - | (557) |
Lease liabilities | | (948) | (1,218) |
| | (11,666) | (18,657) |
Net current assets | | 30,330 | 33,755 |
| |
| |
Non-current liabilities | |
| |
Lease liabilities | | (4,397) | (4,710) |
Provisions | | (300) | (300) |
Other Payables | | (2) | - |
|
| (4,699) | (5,010) |
| |
| |
Total liabilities | | (16,364) | (18,504) |
Net assets | | 58,624 | 62,182 |
Equity | | | |
Share capital | 8 | 7,958 | 7,948 |
Share premium | | 30,011 | 30,011 |
Own shares | 8 | (522) | (566) |
Translation reserve | | 952 | 1,440 |
Other reserves | | 6,256 | 6,256 |
Retained earnings | | 13,969 | 17,093 |
Total equity attributable to the equity shareholders of the parent | |
58,624 | 62,182 |
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHS ENDED 30 JUNE 2025
| Share capital | Share premium | Own shares | Translation reserve | Other reserves | Retained earnings | Total equity |
£'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Balance at 1 January 2024 | 7,923 | 29,950 | (566) | 1,318 | 6,256 | 26,624 | 71,505 |
Loss for the period | - | - | - | - | - | (2,617) | (2,617) |
Other comprehensive expense | - | - | - | 47 | - | - | 47 |
Total comprehensive expense | - | - | - | 47 | - | (2,617) | (2,570) |
Issue of ordinary shares | 14 | 57 | - | - | - | - | 71 |
Exercise of share options | - | - | - | - | - | (7) | (7) |
Share-based payments | - | - | - | - | - | 756 | 756 |
Balance at 30 June 2024 | 7,937 | 30,007 | (566) | 1,365 | 6,256 | 24,756 | 69,755 |
Loss for the period | - | - | - | - | - | (8,075) | (8,075) |
Other comprehensive expense | - | - | - | 75 | - | - | 75 |
Total comprehensive expense | - | - | - | 75 | - | (8,075) | (8,000) |
Issue of ordinary shares | 11 | 4 | - | - | - | - | 15 |
Exercise of share options | - | - | - | - | - | (11) | (11) |
Share-based payments | - | - | - | - | - | 423 | 423 |
Balances at 31 December 2024 | 7,948 | 30,011 | (566) | 1,440 | 6,256 | 17,093 | 62,182 |
Loss for the period | - | - | - | - | - | (3,111) | (3,111) |
Other comprehensive income | - | - | - | (488) | - | - | (488) |
Total comprehensive income/(expense) | - | - | - | (488) | - | (3,111) | (3,599) |
Issue of ordinary shares | 10 | - | - | - | - | - | 10 |
Exercise of share options | - | - | - | - | - | (352) | (352) |
Share-based payments | - | - | - | - | - | 339 | 339 |
Own shares disposed of on exercise of share options | - | - | 342 | - | - | - | 342 |
Purchase of own shares | - | - | (298) | - | - | - | (298) |
Balance at 30 June 2025 | 7,958 | 30,011 | (522) | 952 | 6,256 | 13,969 | 58,624 |
CONDENSED CONSOLIDATED CASH FLOW STATEMENT
FOR THE SIX MONTHS ENDED 30 JUNE 2025
| Six months ended | Six months ended | |
30 June 2025 | 30 June 2024 | ||
(unaudited) | (unaudited) | ||
| Note | £'000 | £'000 |
Cash (utilised)/generated from operations | 11 | (870) | 3,868 |
Net income taxes paid | | (71) | (139) |
Net cash (outflow)/inflow from operating activities | | (941) | 3,729 |
Investing activities | |
| |
Interest income received | | 93 | 57 |
Purchases of property, plant and equipment | | (786) | (373) |
Purchases of intangible assets | | (515) | (35) |
Proceeds from sale of intangible assets | | - | - |
Cash earn-out received from financial asset at FVTPL | | 83 | 73 |
Net cash outflow from investing activities | | (1,125) | (278) |
Financing activities | |
| |
Proceeds from sale of own shares | | (298) | - |
Proceeds from issue of shares | | - | 64 |
Lease payments | | (773) | (883) |
Interest paid | | (29) | (20) |
Net (outflow)/inflow from invoice discounting facility | | (557) | 473 |
Payment of deferred consideration | | - | (1,400) |
Net cash outflow from financing activities | | (1,657) | (1,766) |
Net (decrease)/increase in cash and cash equivalents | | (3,723) | 1,685 |
Cash and cash equivalents at beginning of period | | 8,711 | 7,135 |
Effect of foreign exchange rate changes on cash balances | | 104 | (95) |
Cash and cash equivalents at end of period | | 5,092 | 8,725 |
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED 30 JUNE 2025
1. Basis of preparation and accounting policies
General information
Xaar Plc ("the Company" and together with its subsidiaries "the Group") is a public limited company whose shares are listed on the London Stock Exchange, is incorporated and domiciled in the United Kingdom and is registered in England under the Companies Act 2006.
Basis of preparation
The interim condensed consolidated financial statements for the six months ended 30 June 2025 have been prepared in accordance with IAS 34 "Interim Financial Reporting" as adopted by the United Kingdom. The interim condensed consolidated financial statements do not include all the information and disclosures in the annual financial statements and should be read in conjunction with the Group's consolidated financial statements for the year ended 31 December 2024.
The interim condensed consolidated financial statements are unaudited and do not constitute statutory financial statements as defined in Section 434 of the Companies Act 2006.
The comparative figures for the financial year ended 31 December 2024 are as reported in the Group's consolidated statutory financial statements for that financial year. Those financial statements have been reported on by the Group's Auditor and delivered to the Registrar of Companies. The Independent Auditor's Report for the year ended 31 December 2023 was (i) unqualified, (ii) did not include a reference to any matters to which the Auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under Sections 498(2) or 498(3) of the Companies Act 2006.
Going concern
The Group has prepared the interim condensed consolidated financial statements on the basis that it will continue to operate as a going concern. The Directors consider that there are no material uncertainties that may cast significant doubt over this assumption. They have formed a judgement that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future, and not less than 12 months from the end of the reporting period.
Principal accounting policies
The accounting policies adopted in the preparation of these interim condensed consolidated financial statements are consistent with those followed in the preparation of the Group's annual consolidated financial statements for the year ended 31 December 2024.
New accounting standards, interpretations and amendments
Several amendments apply for the first time in the six months ended 30 June 2025. As previously reported in the Group's Annual Report and Financial Statements for the year ended 31 December 2024, these amendments do not have a material financial or disclosure impact on the Group's interim condensed consolidated financial statements for the six months ended 30 June 2025.
Key sources of estimation uncertainty and critical accounting judgements
In preparing these interim condensed consolidated financial statements, the critical accounting judgements and key sources of estimation uncertainty are consistent with those disclosed in the Group's Annual Report and Financial Statements for the year ended 31 December 2024.
Principal risks and uncertainties
The Board has overall responsibility for the establishment and oversight of the Group's risk management framework. The Board has an established, structured approach to risk management, which includes continuously assessing and monitoring the key risks and uncertainties of the business. An outline of the key risks and uncertainties faced by the Group and the potential impact of these risks on of the Group's strategy and financial performance, together with details of specific mitigating actions, is detailed on pages 13 to 19 of the Group's Annual Report and Financial Statements for the year ended 31 December 2024, which is available on the Group's website at www.xaargroup.com.
The Board has reviewed these risks as part of the half year risk assessment update resulting in several changes which are reflected in the Group's Interim Report for the six months ended 30 June 2025. Details of all such key changes are included in the risks and uncertainties section of this report.
2. Operating segments
The Group's operating segments are determined based on the internal reporting to the Chief Operating Decision Maker (CODM). The CODM has been determined to be the Chief Executive Officer, with support from the other members of the Board of Directors, being the individual who is primarily responsible for the allocation of resources to segments and the assessment of performance of the segments.
The principal activities of the Group are presented in the following segments: 'Printhead', 'Product Print Systems', 'Digital Imaging' and 'Ink Supply Systems'. This presentation reflects how the Group's operating performance is reviewed internally by management.
In 2024 the 'Digital Imaging' business at FFEI was reorganised. The Printbar part of the business was gradually migrated to Printhead operating segment and the Life Sciences business was to be gradually wound down. In Q1 2025 the Life Sciences business ended, resulting in the operating segment 'Digital Imaging' being discontinued. The 2024 figures have been restated to classify the Life Sciences business as discontinued operations.
Six months ended 30 June 2025 (unaudited) | | Printhead | Product Print Systems | Digital Imaging * | Ink Supply Systems | Head Office Entities | Total |
Note | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Revenue - total from continuing operations | | 20,381 | 6,279 | - | 1,704 | - | 28,364 |
Revenue - intra segment | | (502) | - | - | (651) | - | (1,153) |
Revenue - external from continuing operations | | 19,879 | 6,279 | - | 1,053 | - | 27,211 |
| | | | | | | |
Adjusted operating profit/(loss) from continuing operations |
| 2,058 | 195 | - | 311 | (3,078) | (514) |
Adjusting items | 3 | 30 | (300) | - | (45) | (1,767) | (2,082) |
Operating profit/(loss) from continuing operations |
| 2,088 | (105) | - | 266 | (4,845) | (2,596) |
Operating loss from discontinued operations | | - | - | (524) | - | - | (524) |
Total Operating profit/(loss) |
| 2,088 | (105) | (524) | 266 | (4,845) | (3,120) |
Six months ended 30 June 2024 (unaudited) | | Printhead | Product Print Systems | Digital Imaging * | Ink Supply Systems | Head Office Entities | Total |
Note | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Revenue - total from continuing operations | | 17,025 | 7,512 | 645 | 1,580 | - | 26,762 |
Revenue - intra segment | | (501) | - | (449) | (280) | - | (1,229) |
Revenue - external from continuing operations | | 16,524 | 7,512 | 197 | 1,300 | - | 25,533 |
| | | | | | | |
Adjusted operating profit/(loss) from continuing operations | | 1,600 | 480 | (99) | 485 | (2,933) | (468) |
Adjusting items | 3 | (518) | - | (121) | (62) | (620) | (1,321) |
Operating profit/(loss) from continuing operations | | 1,082 | 480 | (220) | 423 | (3,553) | (1,788) |
Operating loss from discontinued operations | | - | - | (822) | - | - | (822) |
Total Operating profit/(loss) | | 1,082 | 480 | (1,042) | 423 | (3,533) | (2,610) |
*restated to identify continuing and discontinued operations. Refer note 12.
Additionally, the share-based payment charge and the management recharges elimination have been allocated and the Head Offices separated from Printhead.
3. Adjusting items
The Directors believe that the 'adjusted profit before tax' and 'adjusted earnings per share' alternative performance measures presented provide a consistent presentation of the Group's underlying operational performance. They also present shareholders with a clearer insight of performance metrics used by the Chief Operating Decision Maker and mitigate volatility, resulting from external factors that are not influenced by the Group.
These items are as defined below and have been presented consistently in both the current and prior interim periods and remain consistent with the audited information as disclosed in the Annual Report and Financial Statements for the year ended 31 December 2024.
|
| Six months ended 30 June 2025 (unaudited) | Six months ended 30 June 2024 (unaudited) - restated | ||||
| | continuing | discontinued | Total | continuing | discontinued | Total |
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Share-based payment charges | (i) | 359 | (3) | 356 | 670 | 100 | 770 |
Exchange gains/(losses) on intra-group transactions | (ii) | 587 | - | 587 | (43) | - | (43) |
Restructuring and transaction expenses | (iii) | 726 | 303 | 1,029 | 243 | 113 | 356 |
Research and Development expenditure credit | (iv) | (181) | - | (181) | - | - | - |
Fair value losses on financial assets at FVTPL | (v) | 426 | - | 426 | 186 | - | 186 |
Amortisation of intangible assets arising on business combinations | (vi) | 165 | - | 165 | 265 | 584 | 849 |
Affecting operating profit and profit before tax |
| 2,082 | 300 | 2,382 | 1,321 | 797 | 2,118 |
Tax effect of adjusting items |
| (16) | - | (16) | - | - | - |
Total adjusting items after tax |
| 2,066 | 300 | 2,366 | 1,321 | 797 | 2,118 |
(i) Comprises share-based payment charges of £356,000 (2024: £756,000) and the corresponding charge of £nil (2024: £14,000) for the associated employer's social security contributions and are included in the selling, general and administrative expenses.
(ii) Comprises exchange gains or losses as a result of intra-group transactions in the United States of America. Such costs are included in selling, general, and administrative expenses.
(iii) Restructuring costs include redundancy costs of £575,000 (2024: £343,000), costs from the rationalisation of the Digital Imaging business £191,000 (2024: nil) and costs resulting from the Group's operational efficiency programs £263,000 (2024: £13,000). Such costs are included in selling, general, and administrative expenses.
(iv) Comprises UK corporation tax relief relating to qualifying research and development expenditure.
(v) Comprises the fair value movement on contingent consideration that arose on the Group's divestment of Xaar 3D Limited. Such costs are included in selling, general, and administrative expenses. Refer to Note 6 for further information.
(vi) The intangible assets consist of the customer relationships and brand value recognised on acquisition of Megnajet Limited in 2022. 2024 also includes the software, patents and customer relationships recognised on acquisition of FFEI Limited in 2021. These costs are included in selling, general, and administrative expenses.
4. Taxation
The major components of the tax credit recognised in the Condensed Consolidated Income Statement are as follows.
Six months ended Six months ended
30 June 2025 30 June 2024
(unaudited) (unaudited)
£'000 £'000
Current tax
Current income tax credit - UK | 45 | - |
Current income tax charge - overseas | 1 | - |
Adjustments in respect of prior years | 4 | (191) |
| 50 | (191) |
Deferred tax
Origination and reversal of timing differences | (201) | - |
| | |
Total tax credit | (151) | (191) |
Unrecognised deferred tax assets
The Group continues to have significant unrecognised deferred tax assets consistent with the position as at 31 December 2024 (£29,546,000). Full details of the nature of these balances are disclosed in note 19 of the Group's Annual Report and Financial Statements for the year ended 31 December 2024.
5. Earnings per share
The calculation of basic and diluted earnings per share is based upon the following data:
| Six months ended 30 June 2025 (unaudited) | Six months ended 30 June 2024 (unaudited) - restated ** | ||||
| Adjusted | Adjusting Items* | Total | Adjusted | Adjusting Items* | Total |
£'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Earnings |
|
|
| | |
|
Loss attributable to equity shareholders of the parent | (745) | (2,366) | (3,111) | (499) | (2,118) | (2,617) |
from continuing | (567) | (2,066) | (2,633) | (451) | (1,321) | (1,772) |
from discontinued operations | (178) | (300) | (478) | (48) | (797) | (845) |
Number of shares
| Six months ended 30 June 2025 (unaudited) | Six months ended 30 June 2024 (unaudited) |
Weighted average number of ordinary shares in issue | 79,188,113 | 78,647,411 |
Less: ordinary shares held by the Xaar Technology Employee Benefit Trust and the Xaar Plc ESOP Trust | (322,730) | (335,556) |
Weighted average number of ordinary shares for the purposes of basic EPS | 78,865,383 | 78,311,855 |
Effect of potential dilutive ordinary shares - share options and awards* | ― | ― |
Weighted average number of ordinary shares for the purposes of diluted EPS | 78,865,383 | 78,311,855 |
*Due to the Group recording a loss in the current and prior period, potentially dilutive shares are not considered within the calculation | ||
Loss per share - Total | Pence per share | Pence per share |
Basic EPS | (3.9) | (3.3) |
Diluted EPS | (3.9) | (3.3) |
Adjusted basic EPS | (0.9) | (0.6) |
Adjusted diluted EPS | (0.9) | (0.6) |
Loss per share - Continuing operations | Pence per share | Pence per share |
Basic EPS | (3.3) | (2.3) |
Diluted EPS | (3.3) | (2.3) |
Adjusted basic EPS | (0.7) | (0.6) |
Adjusted diluted EPS | (0.7) | (0.6) |
** Prior period figures have been restate to separately disclose discontinued operations. Refer note 12.
6. Financial instruments
The Group's activities expose it to a variety of financial risks that include currency risk, interest rate risk, credit risk and liquidity risk.
The interim condensed consolidated financial statements do not include all financial risk management information and disclosures required in the annual financial statements: accordingly, the following disclosures should be read in conjunction with the Group's financial statements for the year ended 31 December 2024.
The Directors consider there to be no material difference between the carrying value and the fair value of financial instruments classified as held at amortised cost. For the items classified as held at fair value, the fair value of such instruments is recognised in the Condensed Consolidated Statement of Financial Position as the carrying amount.
Financial instruments held at fair value
The Group has one financial instrument held at fair value, the contingent consideration that arose on the Group's divestment of its remaining interest in Xaar 3D Limited during the year ended 31 December 2021. The Group received net cash consideration of £9,272,000 as well as a potential entitlement to additional cash consideration of up to £10,863,000 calculated on an earn-out basis at 3% of revenue per annum, with additional amounts becoming receivable on meeting revenue milestones.
Financial instruments that are measured at fair value are classified using a fair value hierarchy that reflects the source of inputs used in deriving the fair value. The three classification levels are:
+ Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;
+ Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and
+ Level 3: from valuation techniques that includes inputs for the asset or liability that are not based on observable market data (i.e. unobservable market inputs.
The financial asset at FVTPL is deemed to be a Level 3 instrument. As at 30 June 2025, fair value has been estimated by assuming a straight line reduction in fair value per percentage change in forecast revenue. Fair value movements are recognised in the Condensed Consolidated Income Statement in selling, general and administrative expenses.
The movement in the carrying value of the financial asset is as follows:
| 30 June 2025 (unaudited) £'000 | 31 December 2024 (audited) £'000 |
Balance at beginning of period/year | 4,918 | 10,599 |
Earn out received | (83) | (73) |
Milestone consideration received | ― | - |
Fair value loss on financial assets at FVTPL* | (422) | (186) |
Balance at end of period/year | 4,413 | 10,340 |
* Includes foreign exchange rate movements
7. Borrowings
| 30 June 2025 (unaudited) £'000 | 31 December 2024 (audited) £'000 |
Amounts falling due within one year Invoice discounting facility |
― |
(1,915) |
Invoice discounting facility
The facility limit is £3 million (2023: £3 million) and operates on a rolling basis from the original inception date of September 2022. The facility can be cancelled with a three-month notice period. There are no covenants attached to the invoice discounting facility.
Interest on the invoice discounting facility is charged daily when the facility is in an overdrawn position at a rate equivalent to the appropriate base rate +1.75% pa. There is an annual service fee of £25,000 charged monthly, and there was a one-off arrangement fee to open the facility of £10,000. No interest is payable on the unutilised element on the facility.
Further details relating to this facility can be found within Note 26 of the Group's consolidated financial statements for the year ended 31 December 2024.
Committed facilities
In June 2023, the Group entered into a Revolving Credit Facility (RCF) agreement of £5 million, which matures in June 2026 . The agreement includes an accordion option of a further £2.5 million which can be requested at any time during the facility term, subject to lender approval and relevant fees. The facility as at 30 June 2025 remained undrawn. (2024: undrawn)
The facility bears a floating interest rate of the Sterling Overnight Indexed Average (SONIA) rate plus 2.35% margin. A non-utilisation fee of 40% of the margin is chargeable on undrawn and uncancelled amounts.
The facility is secured by fixed and floating charges over the assets of the Group. The Group is subject to financial covenants under the facility and has complied with these at all testing points.
8. Share capital
The Company has one class of ordinary shares which carries no right to fixed income.
During the six months ended 30 June 2025, a total of 103,929 new ordinary shares of 10 pence each were issued to satisfy exercises under the Company's LTIP schemes with a £nil exercise price. During the six months ended 30 June 2024, a total of 137,631 new ordinary shares of 10 pence each were issued to satisfy exercises under the Company's LTIP and Save as you earn schemes for £64,000.
During the six months ended 30 June 2025, 143,127 shares with a value of £341,000 (H1 2024: nil) were used by the ESOP to satisfy share award exercises with 276,146 shares purchased by the ESOP for £298,000 (H1 2024: nil).
On 9 April 2025 the Xaar Employee Share Ownership Plan Trust, resolved to purchase £100,000 of ordinary shares in that capital of the company each month commencing 14 April 2025, until further notice.
9. Share-based payments
Long-term incentive plans
During the six months ended 30 June 2025, new options over 1,777,422 shares were granted (2024: 1,462,281) and 229,518 vested options (2024: 71,560) were exercised.
Weighted average fair value of options granted as at 30 June 2025 was 86p (2024: 88p).
Fair value of awards with non-market performance conditions (adjusted profit before tax and revenue) are calculated using the Black Scholes model. Fair values of awards with market-based performance conditions (total shareholder return) are calculated using the Monte Carlo model. The inputs into the models fair value granted in the current and prior periods were as follows:
| Six months ended 30 | Six months ended 30 |
June 2025 | June 2024 | |
Date of grant | 6 May 2025 | 29 April 2024 |
Share price at grant | 105p | 115p |
Exercise price | nil | nil |
Expected volatility | 57.9% | 51.5% |
Risk-free rate | 3.7% | 4.2% |
Contractual life | 3 years | 3 years |
All LTIP awards are subject to achievement of the performance conditions and can be exercised up to ten years after the grant date. Save as permitted in the LTIP rules, awards lapse on an employee leaving the Group.
103,929 of the options exercised were satisfied using shares held by the Xaar Plc ESOP Trust, with the remaining 125,589 being satisfied by the issue of new shares. Options exercised in the period were satisfied in full by the issue of new shares.
Long-term incentive plans (Cash settled)
During the six months ended 30 June 2025, new options over 70,000 shares were granted (2024: nil). These LTIP awards mirror the criteria of our equity settled LTIPS but are specifically to be settled in cash on vesting date.
Deferred bonus plans
No new options were granted in the period (2024: none) and 17,538 vested options were exercised (2024: none). All of the options exercised were satisfied using shares held by the Xaar Plc ESOP Trust.
Save as you earn schemes
No new options were granted in the period (2024: none). No vested options were exercised during the period (2024: 62,524).
10. Dividends
No interim dividend was proposed or paid during either the current or preceding period. The Board of Directors are mindful of the importance of dividends to its shareholders and intends to resume the payment of dividends as soon as conditions allow.
11. Notes to the cash flow statement
| Six months ended | Six months ended |
30 June 2025 | 30 June 2024 | |
(unaudited) | (unaudited) | |
£'000 | £'000 | |
Loss before tax from continuing operations | (2,784) | (1,963) |
Loss before tax from discontinued operations | (478) | (845) |
Loss before tax | (3,262) | (2,808) |
Adjustments for: Depreciation of property, plant and equipment | 1,213 |
1,404 |
Depreciation of right-of-use assets | 378 | 550 |
Amortisation of intangible assets | 216 | 911 |
Net interest expense | 142 | 197 |
Unrealised currency translation losses | 380 | 46 |
Share-based payments charge | 355 | 770 |
Fair value losses on financial assets at FVTPL | 421 | 186 |
Loss on disposal of property, plant and equipment | 8 | - |
Net gain on disposal of leases | - | (5) |
Research and development expenditure credit accrual | (181) | - |
Increase/(decrease) in provisions | 7 | (315) |
Operating cash flows before movements in working capital | (323) | 936 |
Decrease/(increase) in inventories | 157 | (207) |
Decrease in receivables | 96 | 1,316 |
(Decrease)/increase in payables | (800) | 1,823 |
Cash (utilised)/generated from operations | (870) | 3,868 |
Analysis of changes in net debt
| Cash and cash equivalents | Lease liabilities |
Borrowings | Deferred consideration |
Net debt |
£'000 | £'000 | £'000 | £'000 | £'000 | |
Net debt as at 1 January 2024 | 7,135 | (8,698) | (1,403) | (2,115) | (5,081) |
Additions to leases | - | (75) | - | - | (75) |
Cash flows | 1,685 | 883 | (473) | 1,400 | 3,495 |
Foreign exchange and other non-cash movements | (95) | (136) | (39) | (23) | (293) |
Net debt as at 30 June 2024 | 8,725 | (8,026) | (1,915) | (738) | (1,954) |
Additions to leases | - | (415) | - | - | (415) |
Disposals | - | 2,289 | - | - | 2,289 |
Cash flows | (146) | 314 | 1,414 | 733 | 2,315 |
Finance charges | - | (121) | - | - | (121) |
Foreign exchange and other non-cash movements | 132 | 31 | (56) | 5 | 112 |
Net debt as at 31 December 2024 | 8,711 | (5,928) | (557) | - | 2,226 |
Additions to leases | - | (15) | - | - | (15) |
Disposals | - | 4 | - | - | 4 |
Cash flows | (3,723) | 774 | 557 | - | (2,392) |
Finance Charges | - | (164) | - | - | (164) |
Foreign exchange gain/(loss) | 104 | (16) | - | - | 88 |
Net debt as at 30 June 2025 | 5,092 | (5,345) | - | - | (253) |
12. Discontinued operations
In 2024 the 'Digital Imaging' business at FFEI Limited was reorganised. The Printbar part of the business was gradually migrated to Xaar Jet Limited and the Life Sciences business was gradually wound down. In Q1 2025 the Life Sciences business ended, resulting in 'Digital Imaging' being discontinued. The 2024 figures have been restated to classify the Life Sciences business as discontinued operations.
Financial information relating to the 'Digital Imaging' business at FFEI Limited is set out below:
| Six months ended 30 June 2025 (unaudited) | Six months ended 30 June 2024 (unaudited) | ||||
| Continuing | Discontinued | Total | Continuing | Discontinued | Total |
£'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
Revenue | - | 149 | 149 | 197 | 3,107 | 3,304 |
Cost of sales | - | (87) | (87) | (230) | (2,595) | (2,825) |
Gross profit | - | 62 | 62 | (33) | 513 | 480 |
Selling, general and administrative expenses | - | (267) | (267) | (37) | (176) | (213) |
Research and development expenses | - | (18) | (18) | (29) | (362) | (391) |
Adjusting items | - | (300) | (300) | (121) | (797) | (918) |
Operating loss | - | (523) | (523) | (220) | (822) | (1,042) |
Finance income | - | 54 | 54 | 3 | 15 | 18 |
Finance costs | - | (9) | (9) | (8) | (38) | (46) |
Loss before tax | - | (478) | (478) | (224) | (845) | (1,069) |
Tax | - | - | - | - | - | - |
Total loss for the period | - | (478) | (478) | (224) | (845) | (1,069) |
The net cashflows of the 'Digital Imaging' business at FFEI Limited is set out below:
| Six months ended 30 June 2025 (unaudited) | Six months ended 30 June 2024 (unaudited) |
Net cash (outflow) / inflow from operating activities | (1,552) | 2,890 |
Net cash arising from investing activities | 54 | 18 |
Net cash used in financing activities | (177) | (267) |
Net decrease in cash generated by the discontinued operations | (1,674) | (2,642) |
Loss per share - Total | Pence per share | Pence per share |
Basic EPS | (0.6) | (1.1) |
Diluted EPS | (0.6) | (1.1) |
Adjusted basic EPS | (0.2) | (0.1) |
Adjusted diluted EPS | (0.2) | (0.1) |
13. Date of approval of interim financial statements
The interim financial statements cover the period 1 January 2025 to 30 June 2025 and were approved by the Board on 12 August 2025.
Further copies of the interim financial statements are available from the Company's registered office, 3950 Cambridge Research Park, Waterbeach, CB25 9PE, and can be accessed on the Xaar plc website, www.xaargroup.com.
Risks and uncertainties
Several potential risks and uncertainties exist which could have a material impact on the Group's performance over the second half of the financial year and could cause actual results to differ materially from expected and historical results.
The Group has continued identifying, evaluating, and managing the key risks which could impact the Group's performance over the six months to 30 June 2025.
The full list of principal risks identified at the year-end and a description of how they relate to the Group's strategy and the approach to managing them are set out on pages 13 to 19 of the Xaar plc Annual Report and Financial Statements 2024, which is available on the Group's website at www.xaar.com. Management and the Board have reviewed these risks and concluded they will continue to remain relevant for the second half of the financial year. The principal risks as at 30 June 2025, showing any changes from the 2024 year-end disclosure, are summarised in the table below:
Risk Area: Market | ||
Description | Likelihood/Magnitude | Changes since 31 December 2024 |
1. Competition Monitoring and adjusting to competitive dynamics such as pricing/promotion, innovation, resource investments and market share changes | Unlikely/Very High | No change. |
2. Failure to identify market requirements Successfully developing products with the characteristics that meet market requirements within the necessary timescale. | Possible/Very high | No change. |
3. Commercialising and maintaining products with cutting edge technology Creating value by generating innovative products that deliver significant customer benefit. | Possible/Very High | No change. |
4. Merger and acquisition opportunities Our strategy is predicated primarily on organic growth. Seek opportunities to expand, create synergies and generate greater shareholder value. | Possible/Medium | No change. |
Risk Area: Operational | ||
5. Climate change Identifying risks and scenario planning of physical and transition impact upon operations and developing mitigating actions. | Possible/Medium | No change |
6. Organisational capability Having the right people in the right roles. | Possible/High | No change. |
7. Partnerships and alliances Working with the right companies, at the right time on the right terms to deliver long-term value. | Possible/Low | No change. |
8. Supply chain Optimising sourcing and supply chain relationships to drive performance and minimise operational issues. | Possible/Medium | Increased
Impact of US tariffs on the supply chain. |
9. War and Conflicts The war in Ukraine continues to impact the near-term outlook for the UK and global economies and increased uncertainty over the path ahead. Although energy prices have stabilised, they continue to be a concern for the UK economy which also result in further upward pressure on inflation and a potential hit to GDP growth. The conflict between Israel and Hamas has further destabilised the Middle East. | Probable/High | Increased
The recent conflict between Iran and Israel has further destabilised the Middle East. |
10. Laws and regulations Compliance with key laws and regulations in all countries Group operates in. | Possible/Medium | No change. |
Risk Area: IT | ||
11. IT systems and control environment Strengthen IT infrastructure and key IT systems. Enhance and build resilience by investing in and implementing new IT infrastructure or IT systems. | Possible/High | No change. |
12. Cyber security risk Loss of systems or confidential data due to a malicious cyber-attack, leading to disruption to business operations and loss of data. | Probable/High | The incidents of cyber-attacks have increased to other major corporates and organisations over the last six months. |
Risk Area: Financial | ||
13.Ability to access sufficient capital Ability to access sufficient capital to fund growth opportunities. | Unlikely/High | No change. |
14. Customer credit exposure Offering credit terms ensuring recoverability is reasonably assured. | Possible/Low | No change. |
15. Inventory obsolescence Holding excess inventory levels when compared to demand, that leads to increased risk of obsolescence and write-off before consumption. | Probable/High | No change. |
16. Exchange rates Monitoring global economic events and mitigating any resulting significant exchange rate impacts | Probable/Medium | No change |
[1] Centipoise (cP) is a unit of dynamic viscosity used to measure the thickness of a liquid. It is defined as one hundredth of a poise (P). The value indicates how easily the liquid will flow - higher centipoise values correspond to more viscous (thicker) liquids that flow more slowly, while lower centipoise values correspond to less viscous (thinner) liquids that flow more easily. Water has a cP of 1-5, whilst honey has a cP of 2-3,000.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.